Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
|
+$465M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$268M |
| 3 |
Verizon
VZ
|
+$239M |
| 4 |
Microsoft
MSFT
|
+$212M |
| 5 |
Apple
AAPL
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$421M |
| 2 |
Becton Dickinson
BDX
|
+$213M |
| 3 |
Home Depot
HD
|
+$191M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$132M |
| 5 |
Broadcom
AVGO
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.96% |
| 2 | Financials | 12.71% |
| 3 | Healthcare | 11.98% |
| 4 | Consumer Discretionary | 10.85% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVDX
2601
DELISTED
AvidXchange
AVDX
| $2.69M | ﹤0.01% |
+178,916
| New | +$3.74M |
|
2602
Cullinan Oncology
CGEM
$1.01B
| $2.69M | ﹤0.01% |
174,213
+3,469
| +2% | +$69.2K |
|
2603
BioXcel Therapeutics
BTAI
$24.9M
| $2.68M | ﹤0.01% |
8,232
+109
| +1% | +$46.8K |
|
|
RMO
2604
DELISTED
Romeo Power, Inc.
RMO
| $2.67M | ﹤0.01% |
731,907
+57,640
| +9% | +$249K |
|
2605
AvePoint
AVPT
$2.76B
| $2.67M | ﹤0.01% |
424,602
+5,005
| +1% | +$38.8K |
|
2606
Xometry
XMTR
$4.74B
| $2.67M | ﹤0.01% |
52,076
+560
| +1% | +$28.8K |
|
2607
InMode
INMD
$870M
| $2.67M | ﹤0.01% |
+37,800
| New | +$3.03M |
|
2608
FRP Holdings
FRPH
$428M
| $2.67M | ﹤0.01% |
92,194
+994
| +1% | +$28.6K |
|
2609
Tactile Systems Technology
TCMD
$635M
| $2.66M | ﹤0.01% |
139,850
+2,751
| +2% | +$78K |
|
|
GTHX
2610
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $2.66M | ﹤0.01% |
260,701
+20,568
| +9% | +$262K |
|
2611
Rush Enterprises Class B
RUSHB
$6.04B
| $2.63M | ﹤0.01% |
73,015
-399
| -0.5% | -$13.8K |
|
2612
MasterCraft Boat Holdings
MCFT
$579M
| $2.63M | ﹤0.01% |
92,642
+6,746
| +8% | +$184K |
|
2613
UWM Holdings
UWMC
$617M
| $2.62M | ﹤0.01% |
443,119
-3,922
| -0.9% | -$26.5K |
|
|
GAN
2614
DELISTED
GAN Ltd
GAN
| $2.61M | ﹤0.01% |
284,023
+5,978
| +2% | +$73.1K |
|
|
SOVO
2615
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
| $2.61M | ﹤0.01% |
+173,480
| New | +$2.59M |
|
|
APR
2616
DELISTED
Apria, Inc. Common Stock
APR
| $2.6M | ﹤0.01% |
79,868
+10,504
| +15% | +$340K |
|
2617
Precision BioSciences
DTIL
$180M
| $2.59M | ﹤0.01% |
11,654
+539
| +5% | +$151K |
|
|
CCRN
2618
DELISTED
Cross Country Healthcare
CCRN
| $2.59M | ﹤0.01% |
93,153
+3,939
| +4% | +$95.5K |
|
2619
Entravision Communication
EVC
$1.03B
| $2.58M | ﹤0.01% |
381,072
| – | – |
|
2620
Kanzhun
BZ
$7.27B
| $2.56M | ﹤0.01% |
+73,311
| New | +$2.57M |
|
2621
Energy Fuels
UUUU
$2.86B
| $2.56M | ﹤0.01% |
335,170
+17,963
| +6% | +$152K |
|
|
NXDR
2622
Nextdoor Holdings
NXDR
$847M
| $2.56M | ﹤0.01% |
+323,856
| New | +$3.34M |
|
2623
Design Therapeutics
DSGN
$761M
| $2.54M | ﹤0.01% |
118,556
+28,035
| +31% | +$481K |
|
2624
The Honest Company
HNST
$402M
| $2.53M | ﹤0.01% |
313,104
+132,279
| +73% | +$1.16M |
|
2625
Ducommun
DCO
$2.7B
| $2.52M | ﹤0.01% |
53,825
+719
| +1% | +$34.3K |
|
Similar funds
Charles Schwab's Q4 2021 Portfolio in Review
As of Q4 2021, Charles Schwab held 3,647 positions worth $339B, up 11% from $306B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Charles Schwab's Q4 2021 filing shows 148 new, 2,572 increased, 501 reduced and 58 closed positions. Its largest new stake was Kyndryl: 2,951,149 shares worth $53.4M. The largest sale was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, an estimated $421M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q4 2021 buy was Kyndryl: 2,951,149 shares worth $53.4M.
- Charles Schwab added most to State Street SPDR Portfolio Short Term Treasury ETF in Q4 2021, an estimated $465M increase.
- Charles Schwab's biggest Q4 2021 reduction was State Street SPDR Portfolio Intermediate Term Corporate Bond ETF, cutting an estimated $421M.
- Charles Schwab fully exited Kansas City Southern in Q4 2021, selling an estimated $113M.
- Charles Schwab's ten largest holdings make up 18% of its $339B portfolio in Q4 2021.
- Charles Schwab opened 148 new positions and closed 58 in Q4 2021.
- Charles Schwab's portfolio value rose 11% quarter-over-quarter to $339B.
Based on Charles Schwab's 13F filing for Q4 2021, filed 11 Feb 2022.